These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12788348)

  • 1. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents.
    Brouillette WJ; Bajpai SN; Ali SM; Velu SE; Atigadda VR; Lommer BS; Finley JB; Luo M; Air GM
    Bioorg Med Chem; 2003 Jul; 11(13):2739-49. PubMed ID: 12788348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
    Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
    J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.
    Venkatramani L; Johnson ES; Kolavi G; Air GM; Brouillette WJ; Mooers BH
    BMC Struct Biol; 2012 May; 12():7. PubMed ID: 22559154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
    Kati WM; Montgomery D; Carrick R; Gubareva L; Maring C; McDaniel K; Steffy K; Molla A; Hayden F; Kempf D; Kohlbrenner W
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1014-21. PubMed ID: 11897583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.
    Lew W; Wu H; Chen X; Graves BJ; Escarpe PA; MacArthur HL; Mendel DB; Kim CU
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1257-60. PubMed ID: 10866394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors.
    Maring CJ; Stoll VS; Zhao C; Sun M; Krueger AC; Stewart KD; Madigan DL; Kati WM; Xu Y; Carrick RJ; Montgomery DA; Kempf-Grote A; Marsh KC; Molla A; Steffy KR; Sham HL; Laver WG; Gu YG; Kempf DJ; Kohlbrenner WE
    J Med Chem; 2005 Jun; 48(12):3980-90. PubMed ID: 15943472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.
    Li Y; Silamkoti A; Kolavi G; Mou L; Gulati S; Air GM; Brouillette WJ
    Bioorg Med Chem; 2012 Jul; 20(14):4582-9. PubMed ID: 22677529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction.
    Singh S; Jedrzejas MJ; Air GM; Luo M; Laver WG; Brouillette WJ
    J Med Chem; 1995 Aug; 38(17):3217-25. PubMed ID: 7650674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
    Honda T; Masuda T; Yoshida S; Arai M; Kobayashi Y; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1921-4. PubMed ID: 12113809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GS4071 is a slow-binding inhibitor of influenza neuraminidase from both A and B strains.
    Kati WM; Saldivar AS; Mohamadi F; Sham HL; Laver WG; Kohlbrenner WE
    Biochem Biophys Res Commun; 1998 Mar; 244(2):408-13. PubMed ID: 9514938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
    Eichelberger MC; Hassantoufighi A; Wu M; Li M
    Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors.
    Zhang L; Williams MA; Mendel DB; Escarpe PA; Chen X; Wang KY; Graves BJ; Lawton G; Kim CU
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1751-6. PubMed ID: 10406636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
    White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
    J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
    Krueger AC; Xu Y; Kati WM; Kempf DJ; Maring CJ; McDaniel KF; Molla A; Montgomery D; Kohlbrenner WE
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1692-5. PubMed ID: 18242993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of sialidase activity as a therapeutic approach.
    Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
    Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
    Smee DF; Huffman JH; Morrison AC; Barnard DL; Sidwell RW
    Antimicrob Agents Chemother; 2001 Mar; 45(3):743-8. PubMed ID: 11181354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.